The effect of Indomethacin and Betamethasone on the cytokine response of human neonatal mononuclear cells to gram-positive bacteria.
Intrauterine infections with gram-positive bacteria pose a serious threat to neonates since they can result in neonatal sepsis, induce a fetal inflammatory response and also cause preterm birth. Despite intensive care, prematurity remains a leading cause of neonatal death, and is often accompanied by a number of morbidities. In order to prevent premature birth, tocolytic agents like Indomethacin are administered. Betamethasone is used to promote lung maturation and prevent respiratory distress syndrome. A combination of both drugs is assumed to prevent premature delivery while simultaneously facilitating lung maturation. This study investigates the effect of Betamethasone, Indomethacin and a combination of both on the cytokine production of neonatal cord blood mononuclear cells (CBMC) after stimulation with lysates of the gram-positive pathogens Streptococcus agalactiae and Enterococcus faecalis. The aim of the study is to determine the impact of these drugs on the function of the neonatal immune system which should aid clinicians in choosing the optimal therapy in case of preterm birth associated with intrauterine infection. Betamethasone reduced the production of the pro-inflammatory cytokines IL-6, IL-12p40, MIP-1α and TNF and increased the expression of the anti-inflammatory cytokine IL-10, depending on the pathogen used for stimulation. In contrast to Betamethasone, Indomethacin almost exclusively increased IL-10 production. The combination of both drugs decreased the expression of IL-6, IL-12p40, MIP-1α and TNF while increasing IL-10 production, depending on the concentration of Indomethacin and the pathogen used for stimulation. Based on our results, the combination therapy with Indomethacin and Betamethasone has a similar effect on cytokine production as Betamethasone alone, which is generally administered in case of impending preterm birth. However, the combination therapy has the advantage of promoting lung maturation while simultaneously blocking preterm labor effectively.
Clinic of Gynecology and Obstetrics St. Hedwig, University of Regensburg, Regensburg, Germany. Electronic address: Wolfgang.Ernst@ukr.de.
Wolfgang
W
Ernst
Clinic of Gynecology and Obstetrics St. Hedwig, University of Regensburg, Regensburg, Germany.
Evelyn
E
Kusi
Clinic of Gynecology and Obstetrics St. Hedwig, University of Regensburg, Regensburg, Germany.
Sara
S
Fill Malfertheiner
Clinic of Gynecology and Obstetrics St. Hedwig, University of Regensburg, Regensburg, Germany.
Edith
E
Reuschel
Institute of Medical Microbiology, University of Regensburg, Regensburg, Germany; Lophius Biosciences GmbH, Josef-Engert Straße 13, 93053 Regensburg, Germany.
Ludwig
L
Deml
Clinic of Gynecology and Obstetrics St. Hedwig, University of Regensburg, Regensburg, Germany.
Birgit
B
Seelbach-Göbel
D001623:Betamethasone / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism*; D013293:Enterococcus faecalis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D007231:Infant, Newborn; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000502:physiology*
D016207:Cytokines; D001623:Betamethasone; D007213:Indomethacin
Betamethasone; Enterococcus faecalis; Group B streptococcus; Indomethacin; Neonatal sepsis